NDC 57894-514 – Rybrevant Faspro
Amivantamab 2240 mg/14mL; Hyaluronidase (human Recombinant) 28000 mg/14mL · Injection · Subcutaneous
Product NDC57894-514
Product details
- Brand name
- Rybrevant Faspro
- Generic name
- AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761433
- Marketed since
- December 19, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endoglycosidase
Active ingredients
- Amivantamab 2240 mg/14mL
- Hyaluronidase (human Recombinant) 28000 mg/14mL
Uses, dosage, side effects and warnings for Rybrevant Faspro →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 57894-514-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE | Dec 19, 2025 |
Other Rybrevant Faspro products
- 57894-510 Amivantamab 1600 mg/10mL; Hyaluronidase (human Recombinant) 20000… · Injection · Janssen Biotech, Inc.
- 57894-515 Amivantamab 2400 mg/15mL; Hyaluronidase (human Recombinant) 30000… · Injection · Janssen Biotech, Inc.
- 57894-522 Amivantamab 3520 mg/22mL; Hyaluronidase (human Recombinant) 44000… · Injection · Janssen Biotech, Inc.